– Advancing Phase 2 and Phase 3 trials of obexelimab, a unique CD-19 x FcγRIIb inhibitor of B cell function- -Topline results from Phase 2 Trial in Relapsing Multiple Sclerosis (MoonStone) expected in third quarter 2025- -Topline results from pivotal Phase 3 Trial in Immunoglobulin G4-Related Disease (INDIGO) expected year-end 2025- – Enrollment of Phase […]
Perforator Yandex introduces Perforator, a tool that can identify and evaluate code inefficiencies across a company’s entire code base. Perforator helps developers identify the most resource-intensive sections of code and provides detailed statistics for subsequent optimization. The solution can help businesses reduce CPU resource usage by 20% annually. By leveraging Perforator, companies can potentially save […]
Perforator Yandex présente Perforator, un outil capable d’identifier et d’évaluer les inefficacités du code dans l’ensemble de la base de code d’une entreprise. Perforator aide les développeurs à identifier les sections de code les plus gourmandes en ressources et fournit des statistiques détaillées pour une optimisation ultérieure. Le Cette solution peut aider les entreprises à […]
